Laboratory of Molecular Medicine, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Immunol Cell Biol. 2021 Mar;99(3):288-298. doi: 10.1111/imcb.12406. Epub 2020 Oct 25.
Cholesterol is a major component of the lipid bilayers of cellular membranes. The synthesis of cholesterol is acutely elevated during T-cell activation to support T-cell growth and proliferation. There is a limited understanding of cholesterol metabolism reprogramming during T-cell activation. Retinoic acid receptor-related orphan receptors (RORs) are ligand-activated nuclear receptors that regulate the transcription of target genes. In this study, we demonstrated that the activation of RORs by a synthetic agonist (SR1078) impairs the proliferation and survival of postactivated CD8 T cells. The inhibitory effects of SR1078 on CD8 T-cell proliferation and survival were attributed to cholesterol depletion and downregulated expression of cholesterol metabolism-related genes. The overexpression of RORα or RORγt promoted apoptosis in the postactivated CD8 T cells in vitro. The expression of RORα (but not that of RORγt) was markedly upregulated in the CD8 T cells upon stimulation with an antigen in vivo. The functional deficiency of RORα enhanced CD8 T-cell expansion during the response to bacterial infection. These results suggest that RORs are involved in the regulation of CD8 T-cell-mediated immune response through the regulation of cholesterol metabolism, which can be modulated by a synthetic ROR agonist. The findings of this study can aid in the development of immunotherapeutic methods that target nuclear receptors.
胆固醇是细胞膜脂双层的主要成分。在 T 细胞激活期间,胆固醇的合成会急剧升高,以支持 T 细胞的生长和增殖。人们对 T 细胞激活期间胆固醇代谢重编程的了解有限。维甲酸受体相关孤儿受体 (ROR) 是配体激活的核受体,可调节靶基因的转录。在这项研究中,我们证明了合成激动剂 (SR1078) 激活 ROR 会损害已激活的 CD8 T 细胞的增殖和存活。SR1078 对 CD8 T 细胞增殖和存活的抑制作用归因于胆固醇耗竭和胆固醇代谢相关基因表达下调。RORα 或 RORγt 的过表达可促进体外已激活的 CD8 T 细胞凋亡。在体内用抗原刺激后,CD8 T 细胞中 RORα 的表达(但不是 RORγt 的表达)明显上调。RORα 的功能缺陷增强了细菌感染反应期间 CD8 T 细胞的扩增。这些结果表明,ROR 通过调节胆固醇代谢参与调节 CD8 T 细胞介导的免疫反应,而合成的 ROR 激动剂可调节胆固醇代谢。本研究的结果有助于开发针对核受体的免疫治疗方法。